Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04854 |
| Species: | Mus musculus |
| Position : | chr7:46370375-46374302 |
| Year: | 2013 |
| Title: | eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 23993744 |
| Cell Source: | C2C12 |
| CVCL ID: | CVCL_0188 |
| Experiment Type: | TF-binding/chromatin assay |
| High Throughput Method: | ChIP-seq; RNA-seq |
| Low Throughput Method: | ChIP-qPCR/ChIP; RT-qPCR/qPCR; RNAi/siRNA/shRNA |
| Target gene : | Myod1 |
| TF name : | Mef2a |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Mef2a | CDO in myogenesis | reactome | 29 |
| Mef2a | ERK/MAPK targets | reactome | 17 |
| Mef2a | Signaling mediated by p38-alpha and p38-beta | pid | 35 |
| Mef2a | TGF_beta_Receptor | netpath | 220 |
| Mef2a | Hs_p38_MAPK_Signaling_Pathway_WP400_72084 | wikipathways | 28 |